NOA-05 Phase 2 Trial of Procarbazine and Lomustine Therapy in Gliomatosis CerebriGLAS, Martin; BAHR, Oliver; FIMMERS, Rolf et al.Annals of neurology. 2011, Vol 70, Num 3, pp 445-453, issn 0364-5134, 9 p.Article

Intrinsic brainstem choroid plexus papillomaPILLAI, Ashok; RAJEEV, Kariyattil; CHANDI, Sushil et al.Journal of neurosurgery. 2004, Vol 100, Num 6, pp 1076-1078, issn 0022-3085, 3 p.Article

CARBAMOYLATION OF AMINO ACIDS, PEPTIDES, AND PROTEINS BY NITROSOUREAS. = CARBAMOYLATION DES ACIDES AMINES, DES PEPTIDES ET DES PROTEINES PAR LES NITROSOUREESWHEELER GP; BOWDON BJ; STRUCK RF et al.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 11; PP. 2974-2984; BIBL. 1 P. 1/2Article

EFFECT OF CCNU (NSC-79037) ON BRONCHOGENIC CARCINOMATAKITA H; BRUGAROLAS A.1973; J. NATION. CANCER INST.; U.S.A.; DA. 1973; VOL. 50; NO 1; PP. 49-53; BIBL. 6REF.Serial Issue

SERUM ENZYMES IN HEPATOTOXICITY INDUCED BY CHLOROETHYLCYCLOHEXYL NITROSOUREA AND ARABINOFURANOSYL-6-MERCAPTOPURINE = LES ENZYMES DU SERUM DANS L'HEPATOTOXICITE INDUITE PAR LA CHLORETHYLCYCLOHEXYL NITROSOUREE ET PAR L'ARABINOFURANOSYL-6-MERCAPTOPURINEHENRY MC; MARLOW M.1973; TOXICOL. APPL. PHARMACOL.; U.S.A.; DA. 1973; VOL. 24; NO 2; PP. 250-255; BIBL. 12 REF.Serial Issue

FAT EMULSION VEHICLE FOR INTRAVENOUS ADMINISTRATION OF AN AQUEOUS INSOLUBLE DRUGFORTNER CL; GROVE WR; BOWIE D et al.1975; AMER. J. HOSP. PHARM.; U.S.A.; DA. 1975; VOL. 32; NO 6; PP. 582-584; BIBL. 5REF.Article

ZUR THERAPIE DES LYMPHOGRANULOMS. CCNU (1-(2-CHLORAETHYL)-3-ZYKLOHEXYL-1-NITROSOUREA) UND BCNU (1,3-BIS (2-CHLOROAETHYL)-1-NITROSOUREA) SOWIE BCNU-KOMBINATIONEN BEIM LYMPHOGRANULOM HODGKIN, STADIUM III UND IV = SUR LE TRAITEMENT DU LYMPHOGRANULOME. CCNU ((CHLORO-2 ETHYL)-1 CYCLOHEXYL-3 NITROSO-1 UREE) ET BCNU (BIS (CHLORO-2 ETHYL)-1,3 NITROSO-1 UREE) AINSI QUE L'ASSOCIATION BCNU DANS LE LYMPHOGRANULOME DE HODGKIN, STADE III ET IVBRUNNER KW; MAURICE P; SONNTAG RW et al.1972; SCHWEIZ. MED. WSCHR.; SCHWEIZ; DA. 1972; VOL. 102; NO 43; PP. 1546-1551; BIBL. 11 REF.Serial Issue

FATAL PULMONARY TOXIC EFFECTS OF LOMUSTINEDENT RG.1982; THORAX; ISSN 0040-6376; GBR; DA. 1982; VOL. 37; NO 8; PP. 627-629; BIBL. 9 REF.Article

TRIAL OF 1-(2-CHLOROETHYL) 3-CYCLOHEXYL-1-NITROSUREA (CCNU: NSC-79037) IN ADVANCED BRONCHOGENIC CARCINOMASTOLINSKY DC; BULL FE; PAJAK TF et al.1975; ONCOLOGY; SWITZ.; DA. 1975; VOL. 31; NO 5-6; PP. 288-292; BIBL. 4 REF.Article

SEQUENTIAL 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA (NSC79037) AND 5-FLUOROURACIL (NSC19893) THERAPY OF GASTROINTESTINAL CANCER = TRAITEMENT SUCCESSIF PAR LA (CHLORO-2 ETHYL)-1 CYCLOHEXYL-3 NITROSO-1 UREE (NSC79037) ET LE FLUORO-5 URACIL (NSC19893) DU CANCER GASTRO-INTESTINALMOERTEL CG; SCHUTT AJ; REITEMEIER RJ et al.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 6; PP. 1280-1282; BIBL. 5REF.Serial Issue

A COMBINATION OF ADRIAMYCIN, CCNU AND HYDROXYUREA IN THE TREATMENT OF DISSEMINATED BRONCHOGENIC CARCINOMA.ALBERTO P; BARRELET L; CHAPUIS B et al.1975; EUROP. J. CANCER; G.B.; DA. 1975; VOL. 11; NO 11; PP. 795-799; BIBL. 7 REF.Article

A COMPARISON OF THE EFFECTS OF ALKYLATING AGENTS 1,3-BIS-(2-CHLOROETHYL)-1-NITROSOUREA, 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA AND NITROGEN MUSTARD ON NUCLEAR RNA SYNTHESIS AND PROCESSINGABELSON HT; KARLAN D; PENMAN S et al.1974; BIOCHIM. BIOPHYS. ACTA; PAYS-BAS; DA. 1974; VOL. 349; NO 3; PP. 389-401; BIBL. 32REF.Article

Stereoselective monooxygenation of carcinostatic 1-(2-chloroethyl)-3-(cyclohexyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea by purified cytochrome P-450 isozymesPOTTER, D. W; LEVIN, W; RYAN, D. E et al.Biochemical pharmacology. 1984, Vol 33, Num 4, pp 609-613, issn 0006-2952Article

Oral second- and third-line lomustine-etoposide-cyclophosphamide chemotherapy for small cell lung cancerLEBEAU, Bernard; CHOUAÏD, Christos; BAUD, Mariette et al.Lung cancer. 2010, Vol 67, Num 2, pp 188-193, issn 0169-5002, 6 p.Article

PRELIMINARY REPORT ON THE USE OF CCNU (NSC-79037), ADRIAMYCIN (NSC-123127), AND HEXAMETHYLMELAMINE (NSC-13875) IN CARCINOMA OF THE LUNGWILSON WL; ANDREWS NC; FRELICK RW et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 3; PP. 269-271; BIBL. 5 REF.Article

LA CHEMIOTERAPIA DELLE NEOPLASIE DEL SISTEMA NERVOSO CENTRALE = LA CHIMIOTHERAPIE DANS LES TUMEURS DU SYSTEME NERVEUX CENTRALPAOLETTI P.1975; RIV. PATOL. NERV. MENTALE; ITAL.; DA. 1975; VOL. 96; NO 1; PP. 19-34; ABS. ANGL.; BIBL. 2 P. 1/2Article

EFFECT OF CCNU ON SURVIVAL, RATE OF OBJECTIVE REMISSION AND DURATION OF FREE INTERVAL IN PATIENTS WITH MALIGNANT BRAIN GLIOMA-FIRST EVALUATION = INFLUENCE DU CCNU SUR LA SURVIE, LE TAUX DE REMISSION OBJECTIVE ET LA DUREE DE L'INTERVALLE LIBRE DES MALADES AYANT UN GLIOME MALIN1976; EUROP. J. CANCER; G.B.; DA. 1976; VOL. 12; NO 1; PP. 41-45; BIBL. 7 REF.Article

A RANDOMIZED PILOT STUDY COMPARING TWO REGIMENS IN THE TREATMENT OF SQUAMOUS CELL CARCINOMAMOSELEY HS; SASAKI T; MCCONNELL DB et al.1976; J. SURG. ONCOL.; U.S.A.; DA. 1976; VOL. 8; NO 1; PP. 35-42; BIBL. 11 REF.Article

CCNU (NSC-79037): PRECLINICAL TOXICOLOGIC EVALUATION OF A SINGLE INTRAVENOUS INFUSION IN DOGS AND MONKEYS = CCNU (NSC 79037) TOXICOLOGIE PRECLINIQUE D'UNE PERFUSION UNIQUE INTRAVEINEUSE CHEZ LE CHIEN ET LE SINGESCHAEPPI U; FLEISCHMAN RW; PHELAN RS et al.1974; CANCER CHEMOTHERAPY REP., 3; U.S.A.; DA. 1974; VOL. 5; NO 1; PP. 53-64; BIBL. 22REF.Article

Combination of lomustine and cimetidine in the treatment of a patient with malignant glioblastoma: a case reportHESS, W. A; KORNBLITH, P. L.Cancer treatment reports. 1985, Vol 69, Num 6, issn 0361-5960, 733Article

Chemopotentiation of CCNU metabolites by misonidazoleMULCAHY, R. T.British journal of cancer. 1985, Vol 51, Num 5, pp 733-735, issn 0007-0920Article

Les technologies d'embolisation sélective, l'utilisation des microsphères = The techniques of selective embolization, the use of microspheresBENOIT, J. P; MADOULE, P; TRAMPONT, P et al.Innovation et technologie en biologie et médecine. 1986, Vol 7, Num 2, pp 137-151, issn 0243-7228Article

DISTRIBUTION OF ¹⁴C-LOMUSTINE (¹⁴C-CCNU)-DERIVED RADIOACTIVITY FOLLOWING INTRAVENOUS ADMINISTRATION OF THREE POTENTIAL CLINICAL FORMULATIONS TO RABBITSLITTERST CL; MIMNAUGH EG; COWLES AC et al.1974; J. PHARM. SCI.; U.S.A.; DA. 1974; VOL. 63; NO 11; PP. 1718-1721; BIBL. 16REF.Article

URINARY METABOLITES OF 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA AND 1-(2-CHLOROETHYL)-3-(TRANS-4-METHYLCYCLOHEXYL)-1-NITROSOUREAKOHLHEPP SJ; MAY HE; REED DJ et al.1981; DRUG METAB. DISPOS.; ISSN 0090-9556; USA; DA. 1981; VOL. 9; NO 2; PP. 135-141; BIBL. 20 REF.Article

CARDIOTOXICITY OF 5-FLUOROURACILGAMUCCI T; ZAMPA G.1980; TUMORI; ISSN 0300-8916; ITA; DA. 1980; VOL. 66; NO 5; PP. 635-636; ABS. ITA; BIBL. 8 REF.Article